Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Latest filing published 06 Feb 2026 for Azenta, Inc., €134k.
Insider track record
Disclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Tina Susan Nova: trading record in brief
Filings by Tina Susan Nova span 4 companies, the busiest being Arena Pharmaceuticals Inc, Azenta, Inc. and Veracyte, Inc. Between 13 June 2018 and 6 February 2026, the trades on record add up to 19 filings.
Sales make up the whole of the open-market record (2 sales, €1.0M). The rest of the record consists of 11 share grants and 4 option exercises.
On 6 February 2026 came the latest disclosure, a share grant for €134k in Azenta, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Tina Susan Nova
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
5,663 shares@ US$27.8527.4% of flowCommonSEC:0001193125-26-041527:0
4,040 shares@ US$52.3257.5% of flowCommonSEC:0000950170-25-017893:0
2,465 shares@ US$65.9342.5% of flowCommonSEC:0000950170-24-014558:0
3,604 shares0Common StockSEC:0001209191-23-009725:0
17,776 sharesCommon StockSEC:0001628280-22-005918:0
56,546 shares0Common StockSEC:0001384101-22-000052:0
10,695 shares@ US$27.84100.0% of flowCommon StockSEC:0001384101-22-000038:0
3,067 shares0Common StockSEC:0001628280-21-012279:0
8 of 8 declarations
